Results 1 to 10 of about 559,157 (325)
Military and Medical Expertise in Patients with Central Retinal Degeneration [PDF]
Last years pathological processes of the retina became a worldwide problem among people of different ages and this group includes a various number of central retinal degenerations. There is a vivid tendency for these types of diseases to become younger last years.
Ignatiev Sergei
openalex +2 more sources
Non-medical treatment for late age-related macular degeneration [PDF]
Age-related macular degeneration (AMD) is the leading cause of blindness in people over 55 in developed countries. Moreover, the number of these patients will increase growth as life expectancy increases. It is estimated that late AMD accounts for half of blindness and low vision cases in European countries. A myriad of studies is currently underway to
А. К. Дракон +3 more
openalex +3 more sources
Early calcific degeneration of the St. Jude Medical Epic aortic bioprosthesis [PDF]
AbstractThis report highlights the need for close surveillance of bioprosthetic valves. Unaccountable degeneration of bioprosthetic valves can develop early after implantation and usually requires replacing the failed valve with a mechanical prosthesis.
Mohammad Bashar Izzat +2 more
openalex +4 more sources
Enhancing medical explainability in deep learning for age-related macular degeneration diagnosis [PDF]
Deep learning models hold significant promise for disease diagnosis but often lack transparency in their decision-making processes, limiting trust and hindering clinical adoption. This study introduces a novel multi-task learning framework to enhance the medical explainability of deep learning models for diagnosing age-related macular degeneration (AMD)
Lihua Shi
openalex +4 more sources
The current state and issues of medical treatment for age-related macular degeneration
滲出型加齢黄斑変性の中心的病態は,脈絡膜血管新生であり,新生血管の透過性亢進による滲出性変化が神経網膜を恒久的に傷害する.近年の細胞生物学の進歩は,これらの病態における複数の分子メカニズムを明らかにしてきたため,特定の分子を標的とした阻害薬が開発される時代になった.なかでも血管内皮増殖因子(VEGF)は,進行の鍵となる2つの病態,血管新生・血管透過性亢進を促進することが明らかにされ,その阻害薬の臨床応用が実現した.眼科領域で臨床応用されたVEGF阻害薬pegaptanib(Macugen®),ranibizumab(Lucentis®),bevacizumab(Avastin®)は,黄斑浮腫・剥離や血管新生を軽減させ,少なくとも短期的には有効であることがわかった.しかし,至適な投与法,長期の安全性 ...
Susumu Ishida
openalex +4 more sources
This article examines how Colombian doctors and public health officials during the last decades of the nineteenth century produced a body of knowledge about the health of the nation's citizens, using the language and authority of science to speak about a society in need of redemption and medical intervention.
Hanni Jalil Paier
openalex +5 more sources
Medication Trends for Age-Related Macular Degeneration [PDF]
Age-related macular degeneration (AMD) is central vision loss with aging, was the fourth main cause of blindness in 2015, and has many risk factors, such as cataract surgery, cigarette smoking, family history, hypertension, obesity, long-term smart device usage, etc. AMD is classified into three categories: normal AMD, early AMD, and late AMD, based on
Yeon-Kyoung Cho +2 more
openaire +2 more sources
The Study of Crime and Degeneration from a Medical Standpoint [PDF]
Willis S. Anderson
openalex +3 more sources
Assessing the Viability and Degeneration of the Medically Important Filarial Nematodes
Charles D. Mackenzie +3 more
+6 more sources
What is Degeneration of Intervertebral Disc, Cause and Its Medical Management? [PDF]
Priyanka Kumari
openalex +2 more sources

